The growth of clinical trials and systematic reviews in informing dermatological patient care

Journal of Investigative Dermatology

Volumn 132, Issue 3 PART 2, 2012, Pages 1008-1017

  Williams, Hywel C ^a   Dellavalle, Robert P ^b,c,d,e  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e Global Health and Health Disparities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ACNE; ATOPIC DERMATITIS; CLINICAL TRIAL (TOPIC); DERMATOLOGY; DISEASE CONTROL; HUMAN; MEDICAL LITERATURE; MEDICAL PRACTICE; MELANOMA; META ANALYSIS (TOPIC); MORTALITY; PATIENT CARE; PEMPHIGOID; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PSORIASIS; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN CARE; SYSTEMATIC REVIEW (TOPIC);

EID: 84856865636     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.337     Document Type: Review

References (92)

1. Alvarez F, Meyer N, Gourraud PA et al. (2009) CONSORT adoption and quality of reporting of randomized controlled trials: A systematic analysis in two dermatology journals. Br J Dermatol 161:1159-65
2. Ashcroft DM, Chen LC, Garside R et al. (2007) Topical pimecrolimus for eczema. Cochrane Database Syst Rev (4):CD005500
3. Brierley G, Brabyn S, Torgerson D et al. (2011) Bias in recruitment to cluster randomized trials: A review of recent publications. J Eval Clin Pract; e-pub ahead of print 20 June 2011; doi:10.1111/j.1365-2753.2011.01700.x
4. Carson KR, Focosi D, Major EO et al. (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: A Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10:816-24
5. Chalmers I, Glasziou P (2009) Avoidable waste in the production and reporting of research evidence. Lancet 374:86-9
6. Chan AW, Hróbjartsson A, Haahr MT et al. (2004) Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 291:2457-65 (Pubitemid 38669189)
7. Chren M-M (2012) The contribution of health services research to improved dermatological care. J Invest Dermatol (this issue)
8. Clarke M, Hopewell S, Chalmers I (2010) Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet 376:20-1
9. Collier A, Johnson KR, Delamere F et al. (2005a) The Cochrane Skin Group: Promoting the best evidence. J Cutan Med Surg 9:324-31
10. Collier A, Johnson K, Heilig L et al. (2005b) A win-win proposition: Fostering US health care consumer involvement in the Cochrane Collaboration Skin Group. J Am Acad Dermatol 53:920-1 (Pubitemid 41501408)
11. Collier A, Heilig L, Schilling L et al. (2006) Cochrane Skin Group systematic reviews are more methodologically rigorous than other systematic reviews in dermatology. Br J Dermatol 155:1230-5 (Pubitemid 44730000)
12. Committee on Quality of Health Care in America, Institute of Medicine (2001) Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press
13. Cook T, DeMets DL (2010) Review of draft FDA adaptive design guidance. J Biopharm Stat 20:1132-42
14. De Angelis C, Drazen JM, Frizelle FA et al. (2004) Clinical trial registration: A statement from the International Committee of Medical Journal Editors. Ann Intern Med 141:477-8 (Pubitemid 39281885)
15. Dellavalle RP, Drake A, Graber M et al. (2005) Statins and fibrates for preventing melanoma. Cochrane Database Syst Rev (4):CD003697
16. Eaglstein WH (2010) Evidence-based medicine, the research-practice gap, and biases in medical and surgical decision making in dermatology. Arch Dermatol 146:1161-4
17. Easterbrook PJ, Gopalan R, Berlin JA et al. (1991) Publication bias in clinical research. Lancet 337:867-72
18. Eleftheriadou V, Whitton ME, Gawkrodger DJ et al. (2011) Vitiligo priority setting partnership. Future research into the treatment of vitiligo: Where should our priorities lie? Results of the vitiligo priority setting partnership. Br J Dermatol 164:530-6
19. Faye O, Roujeau JC (2005) Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): Clinical experience to date. Drugs 65:2085-90 (Pubitemid 41475790)
20. Ferner RE, Moss C (1996) Minocycline for acne. BMJ 312:138 (Pubitemid 26026280)
21. Gluud C, Sørensen T (1995) New developments in the conduct and management of multi-center trials: An international review of clinical trial units. Fundam Clin Pharmacol 9:284-9
22. Godlee F (2010) More research is needed-but what type? BMJ 341:c4662
23. Gøtzsche PC, Jørgensen AW (2011) Opening up data at the European Medicines Agency. BMJ 342:d2686
24. Green A, Williams G, Neale R et al. (1999) Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomised controlled trial (published erratum appears in Lancet; 354: 1038, 1999). Lancet 354: 723-9 (Pubitemid 29438440)
25. Green AC, Williams GM, Logan V et al. (2011) Reduced melanoma after regular sunscreen use: Randomized trial follow-up. J Clin Oncol 29:257-63
26. Greene RE, Freeman SR, Lundahl K et al. (2008) Co-publishing Cochrane Library systematic reviews: Journal editor and Cochrane Skin Group author experiences. Br J Dermatol 158:1380-2 (Pubitemid 351692879)
27. Guyatt G, Oxman AD, Aki EA et al. (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383-94
28. Hadley G, Derry S, Moore RA (2006) Imiquimod for actinic keratoses: Systematic review and meta-analysis. J Invest Dermatol 126:1251-5 (Pubitemid 43997904)
29. Holmes MV, Shah T, Vickery C et al. (2009) Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies. PLoS One 4:e7960
30. Higgins JPT, Green S (eds) (2008) Cochrane Handbook for Systematic Reviews of Interventions. West Sussex: Wiley-Blackwell 649 pp
31. Higgins JPT, Green S (eds) (2011) Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook. org (accessed 23 July 2011)
32. Hoare C, Li Wan Po A, Williams H (2000) Systematic review of treatments for atopic eczema. Health Technol Assess 4:1-191
33. Hoch HE, Busse KL, Dellavalle RP (2009) Consumer empowerment in dermatology. Dermatol Clin 27:177-83
34. Honigmann P, Fischer H, Kurmann A et al. (2007) Investigating the effect of intra-operative infiltration with local anaesthesia on the development of chronic postoperative pain after inguinal hernia repair. A randomized placebo controlled triple blinded and group sequential study design [NCT00484731]. BMC Surg 7:22
35. Ingram JR, Grindlay JC, Williams HC (2010) Problems in the reporting of acne clinical trials: A spot check from the 2009 annual evidence update on acne vulgaris. Trials 11:77
36. Ioannidis JP (2005) Contradicted and initially stronger effects in highly cited clinical research. JAMA 294:218-28 (Pubitemid 41043792)
37. Joly P, Roujeau JC, Benichou J et al., Bullous Diseases French Study Group (2002) A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 346:321-7 (Pubitemid 34438839)
38. Joly P, Roujeau JC, Benichou J et al. (2009) A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: A multicenter randomized study. J Invest Dermatol 129:1681-7
39. Kérob D, Porcher R, Vérola O et al. (2010) Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: Results of a multicenter phase II study on 25 patients. Clin Cancer Res 16:3288-95
40. Kirtschig G, Middleton P, Bennett C et al. (2010) Interventions for bullous pemphigoid. Cochrane Database Syst Rev (10):CD002292
41. Langan SM, Smeeth L, Hubbard R et al. (2008) Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: Population based cohort study. BMJ 337:a180
42. Langan SM, Thomas K, Williams HC (2006) What is meant by a ''flare'' in atopic dermatitis? A systematic review and proposal. Arch Dermatol 142:1190-6 (Pubitemid 44414402)
43. Layfield C, Clarke T, Thomas K et al. (2011) Developing a network in a neglected area of clinical research the UK Dermatology Clinical Trials Network. Clin Invest 1:943-9
44. Lehmann HP, Andrews JS, Robinson KA et al. (2001) Management of acne. US Agency for Healthcare Research and Quality (AHRQ) Evidence Report/Technology Assessment Number 17; September 2001
45. Liberati A, Altman DG, Tetzlaff J et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 6:e1000100
46. Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23:3105-24 (Pubitemid 39334902)
47. Mason AR, Mason J, Cork M et al. (2009) Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev (2):CD005028
48. Moher D, Tetzlaff J, Tricco AC et al. (2007) Epidemiology and reporting characteristics of systematic reviews. PLoS Med 4:e78
49. Murrell DF, Dick S, Ahmed AR et al. (2008) Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 58:1043-6
50. Naldi N, Svensson A, Diepgen T et al. (2003) on behalf of The European Dermato-Epidemiology Network (EDEN). Randomized clinical trials for psoriasis 1987-2000: The EDEN Survey. J Invest Dermatol 120:738-41 (Pubitemid 36529071)
51. Naldi L, Chatenoud L, Bertuccio P et al., Oncology Cooperative Group of the Italian Group for Epidemiologic Research in Dermatology (GISED) (2007) Improving sun-protection behavior among children: Results of a cluster-randomized trial in Italian elementary schools. The ''SoleSi SoleNo-GISED'' Project. J Invest Dermatol 127:1871-7
52. Naldi L, Svensson A, Zenoni D et al., on behalf of the European Dermato-Epidemiology Network (EDEN) (2010) Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: Update of the EDEN Psoriasis Survey 2001-2006. Br J Dermatol 162:384-9
53. Nankervis H, Maplethorpe A, Williams HC (2011) Mapping randomised controlled trials of treatments for eczema-the GREAT database. BMC Dermatol 11:10
54. Ozolins M, Eady EA, Avery AJ et al. (2004) Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: Randomised controlled trial. Lancet 364:2188-95 (Pubitemid 40018448)
55. Palepu A, Kendall C, Moher D (2011) Open medicine endorses PROSERO. Open Medicine, North America, 5 March. Available at http://www. openmedicine.ca/ article/view/464
56. Parker ER, Schilling LM, Diba V et al. (2004) What is the point of databases of reviews for dermatology if all they compile is ''insufficient evidence''? J Am Acad Dermatol 50:635-9 (Pubitemid 38393177)
57. Patsopoulos NA, Analatos AA, Ioannidis JP (2005) Relative citation impact of various study designs in the health sciences. JAMA 293:2362-6 (Pubitemid 40676758)
58. Peto R, Collins R, Gray R (1995) Large-scale randomized evidence: Large, simple trials and overviews of trials. J Clin Epidemiol 48:23-40
59. Petrou S, Gray A (2011) Economic evaluation using decision analytical modelling: Design, conduct, analysis, and reporting. BMJ 342:d1766
60. Rising K, Bacchetti P, Bero L (2008) Reporting bias in drug trials submitted to the Food and Drug Administration: Review of publication and presentation (published erratum appears in PLoS Med; 6). PLoS Med 5:e217; discussion e217
61. Roland M, Torgerson DJ (1998) What are pragmatic trials? BMJ 316:285
62. Roseman M, Milette K, Bero LA et al. (2011) Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA 305: 1008-17
63. Sackett DL, Wennberg JE (1997) Choosing the best research design for each question. BMJ 3153:1636 (Pubitemid 28014773)
64. Savoie I, Helmer D, Green CJ et al. (2003) Beyond Medline: Reducing bias through extended systematic review search. Int J Technol Assess Health Care 19:168-78 (Pubitemid 36356337)
65. Schlosser RW, Wendt O, Angermeier K et al. (2005) Searching for and finding evidence in augmentative and alternative communication: Navigating a scattered literature. Augment Altern Commun 21:33-255
66. Schmitt J, Langan S, Stamm T et al., on behalf of the Harmonizing Outcome Measurements in Eczema (HOME) Delphi Panel (2011a) Core outcome domains for controlled trials and clinical recordkeeping in eczema: International multi-perspective Delphi consensus process. J Invest Dermatol 131:623-30
67. Schmitt J, Langan S, Williams HC, and the European Dermato-Epidemiology Network (2007) What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 120:1389-98 (Pubitemid 350216596)
68. Schmitt J, von Kobyletzki L, Svensson A et al. (2011b) Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: Systematic review and meta-analysis of randomized controlled trials. Br J Dermatol 164:415-28
69. Schultz KF, Altman DG, Moher D (2010) the CONSORT Group: CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel-Group Randomized Trials. Trials 11:32
70. Shojania KG, Sampson M, Ansari MT et al. (2007) How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med 147: 224-33 (Pubitemid 351664578)
71. Sox HC, Greenfield S (2009) Comparative effectiveness research: A report from the Institute of Medicine. Ann Intern Med 151:203-5
72. Spiegelhalter DJ, Myles JP, Jones DR et al. (2000) Bayesian methods in health technology assessment: A review. Health Technol Assess 4:1-130
73. Spuls PI, Lecluse LL, Puolsen ML et al. (2010) How good are clinical severity and outcome measures for psoriasis?: Quantitative evaluation in a systematic review. J Invest Dermatol 130:933-43
74. Straus SE, Richardson WS, Glasziou P et al. (eds). (2005) Evidence Based Medicine, 3rd edn. Edinburgh: Churchill Livingston 320 pp
75. Teagarden JR (1989) Meta-analysis: Whither narrative review? Pharmacotherapy 9:274-81
76. The Cardiac Arrhythmia Suppression Trial II Investigators (1992) Effects of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 327:227-33
77. Thorpe KE, Zwarenstein M, Oxman AD et al. (2009) A pragmatic-explanatory continuum indicator summary (PRECIS): A tool to help trial designers. J Clin Epidemiol 62:464-75
78. Townshend AP, Chen C-M, Williams HC (2008) How prominent are patient reported outcomes in clinical trials of dermatological treatments? Br J Dermatol 159:1152-9
79. Tricco AC, Straus SE, Moher D (2011) How can we improve the interpretation of systematic reviews? BMC Med 9:31
80. Turner RM, Omar RZ, Thompson SG (2001) Bayesian methods of analysis for cluster randomized trials with binary outcome data. Stat Med 20:453-72 (Pubitemid 32125133)
81. van Coevorden M, Coenraads PJ, Svensson A et al. (2004) Overview of therapeutic studies of treatment for hand eczema-the EDEN hand eczema survey. Br J Dermatol 151:446-7
82. van der Pols JC, Williams GM, Pandeya N et al. (2006) Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 15:2546-8 (Pubitemid 46048320)
83. van der Wouden JC, van der Sande R, van Suijlekom-Smit LWA et al. (2009) Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev (4):CD004767
84. Vickers AJ, Scardino PT (2009) The clinically-integrated randomized trial: Proposed novel method for conducting large trials at low cost. Trials 10:14
85. Whitton ME, Pinart M, Batchelor J et al. (2010) Interventions for vitiligo. Cochrane Database Syst Rev (1):CD003263
86. Williams HC (2010) Cars, CONSORT 2010 and clinical practice. Trials 11:33
87. Williams HC (2011) Preventing eczema flares with topical corticosteroids or tacrolimus: Which is best? Br J Dermatol 164:231-3
88. Williams HC, Bigby M (2008) The rationale for evidence-based dermatology. In: Evidence-Based Dermatology (Williams HC, Bigby M, Diepgen T, eds), 2nd edn. Oxford: Blackwell Publishing and BMJ Publishing Group, pp 8-13
89. Williams HC, Garner S, Dellavalle RP (2011) Acne vulgaris. Lancet; e-pub ahead of print 29 August 2011
90. Williams HC, Goldsmith L (2006) The JID opens its doors to high quality randomised controlled clinical trials. J Invest Dermatol 126:1683-4 (Pubitemid 44086498)
91. Williams HC, Stern RS (2005) Prospective trials registration. J Invest Derm 124:vii
92. Wolkenstein P, Latarjet J, Roujeau JC et al. (1998) Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 352:1586-9 (Pubitemid 28515243)